User profiles for Steven E Kahn
![]() | Steven E. KahnVA Puget Sound Health Care System and University of Washington Verified email at uw.edu Cited by 131807 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
SE Kahn, SM Haffner, MA Heise…�- …�England Journal of�…, 2006 - Mass Medical Soc
Background The efficacy of thiazolidinediones, as compared with other oral glucose-lowering
medications, in maintaining long-term glycemic control in type 2 diabetes is not known. …
medications, in maintaining long-term glycemic control in type 2 diabetes is not known. …
Mechanisms linking obesity to insulin resistance and type 2 diabetes
SE Kahn, RL Hull, KM Utzschneider�- Nature, 2006 - nature.com
Obesity is associated with an increased risk of developing insulin resistance and type 2
diabetes. In obese individuals, adipose tissue releases increased amounts of non-esterified fatty …
diabetes. In obese individuals, adipose tissue releases increased amounts of non-esterified fatty …
Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function
To determine the relationship between insulin sensitivity and β-cell function, we quantified the
insulin sensitivity index using the minimal model in 93 relatively young, apparently healthy …
insulin sensitivity index using the minimal model in 93 relatively young, apparently healthy …
The importance of β-cell failure in the development and progression of type 2 diabetes
SE Kahn�- The Journal of Clinical Endocrinology & Metabolism, 2001 - academic.oup.com
… *Address all correspondence and requests for reprints to: Steven E. Kahn MB, Ch.B.,
Veterans Affairs Puget Sound Health Care System (151), 1660 South Columbian Way, Seattle, …
Veterans Affairs Puget Sound Health Care System (151), 1660 South Columbian Way, Seattle, …
Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
RH Eckel, SE Kahn, E Ferrannini…�- The Journal of�…, 2011 - academic.oup.com
Objective: This report examines what is known about the relationship between obesity and
type 2 diabetes and how future research in these areas might be directed to benefit prevention…
type 2 diabetes and how future research in these areas might be directed to benefit prevention…
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Glucose metabolism is normally regulated by a feedback loop including islet β cells and
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell response…
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell response…
Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells
SE Kahn, DA D'Alessio, MW Schwartz, WY Fujimoto…�- Diabetes, 1990 - Am Diabetes Assoc
… Address correspondence and reprint requests to Steven E. Kahn, MB, ChB, VA Medical
Center (151), 1660 South Columbian Way, Seattle WA 98108. Received for publication 29 …
Center (151), 1660 South Columbian Way, Seattle WA 98108. Received for publication 29 …
The role of insulin resistance in nonalcoholic fatty liver disease
KM Utzschneider, SE Kahn�- The Journal of Clinical�…, 2006 - academic.oup.com
Context: Insulin resistance is an almost universal finding in nonalcoholic fatty liver disease (NAFLD).
This review outlines the evidence linking insulin resistance and NAFLD, explores …
This review outlines the evidence linking insulin resistance and NAFLD, explores …
[HTML][HTML] Semaglutide and cardiovascular outcomes in obesity without diabetes
…, S Hardt-Lindberg, GK Hovingh, SE Kahn…�- …�England Journal of�…, 2023 - Mass Medical Soc
Background Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to
reduce the risk of adverse cardiovascular events in patients with diabetes. Whether …
reduce the risk of adverse cardiovascular events in patients with diabetes. Whether …
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT)
OBJECTIVE—The purpose of this study was to examine possible factors associated with the
increased risk of fractures observed with rosiglitazone in A Diabetes Outcome Progression …
increased risk of fractures observed with rosiglitazone in A Diabetes Outcome Progression …